MARKET TRENDS
7 Aug 2025
INVESTMENT
30 Jul 2025
TECHNOLOGY
16 Jul 2025
PARTNERSHIPS
10 Jul 2025
RESEARCH
4 Jul 2025
CRISPR therapy cuts LDL by 86% in a single dose, hinting at a future where gene editing replaces daily heart meds.
REGULATORY
17 Jun 2025
FDA speeds cell and gene therapy reviews, aiming for faster access without lowering safety standards.
INNOVATION
5 Jun 2025
Sector turns to next-generation delivery and risk controls as in vivo gene editing moves toward wider clinical use
PARTNERSHIPS
21 May 2025
CHOP, Penn, and Acuitas use lipid nanoparticles for rare genetic disorder, bypassing viral vectors for the first time in the US.
INSIGHTS
15 May 2025
Mammoth’s one-dose CRISPR delivery to muscle raises hopes for wider, safer genetic treatments.
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.